What is life science?

Life science encompasses research, products and methods aimed at preventing, diagnosing or treating diseases and improving human health. KDventures primarily invests in innovative pharmaceutical, biotech and medical technology companies.

From research to market

Drug development consists of several stages and requires significant investment over a long period. As a project moves from research to clinical studies, parts of the development risk decrease, while opportunities for partnerships, licensing agreements and other value-creating deals may increase.

Drug development

Preclinical research

New biological targets and potential drug candidates are identified and tested in laboratory models.

Preclinical development

The drug candidate is investigated further, focusing on areas such as safety, dosing and the prerequisites for clinical studies.

Phase 1

The candidate is tested in humans for the first time, usually focusing on safety, tolerability and how the drug is absorbed and metabolised in the body.

Phase 2

The treatment is studied in patients to evaluate efficacy, safety and appropriate dosing.

Phase 3

Efficacy and safety are evaluated in larger patient groups as the basis for an application for marketing authorisation.

Registration

The results from the development programme are compiled and submitted to the relevant medicines authorities for review.

Market launch

After approval, the treatment can be launched. Pricing, reimbursement, distribution and commercial organisation are key parts of the market introduction.

Medical technology

Development and market introduction of medical technology products. Medical technology products include everything from diagnostic aids and implants to advanced treatment equipment. The development and approval process varies depending on the product's risk class, intended use and market.

In the EU, CE marking is normally required before the product may be sold. In the US, medical technology products are regulated by the FDA. After regulatory approval, clinical use, reimbursement systems and commercial establishment are crucial for the market introduction.